B Vitamins
Most healthy adults eating a mixed diet don't need a B-complex pill. Four groups do need to watch their vitamin B12, the B6 dose on the label matters more than the form, and in trials the payoff for the brain is very small and for the heart is limited to a small cut in stroke.
If you are vegan or vegetarian, take 25–250 µg of B12 a day without waiting for a test. If you take metformin long term, consider periodic B12 checks; if you take acid-suppressing drugs long term or are past about 60, get checked if you have symptoms such as tiredness or tingling. For any of these groups a cheap low-dose supplement is an alternative. Otherwise skip the B-complex, and if you do take one, keep its B6 under 12 mg a day.
Who actually needs them
The eight B vitamins are coenzymes: small molecules that enzymes need to run energy metabolism, DNA synthesis and the clearing of homocysteine, an amino acid that is toxic at high levels. Classic deficiency diseases are rare in well-fed populations, and a healthy adult eating animal products and a reasonable variety of plants gets plenty. Mega-dosing a B-complex on top does not noticeably improve energy, mood or cognition in people who aren't deficient, though the category is marketed almost entirely on that promise.
B12 is the exception, for four groups:
- Vegetarians and especially vegans. Plant foods contain essentially no B12; it is made by bacteria and reaches us through animal products. Supplement without waiting for a test.
- Long-term metformin users. The diabetes drug interferes with how the gut absorbs B12. In a large US diabetes-prevention study followed for about 13 years, each extra year of metformin was linked to about 13% higher odds of low B12, and low or borderline-low B12 was more common on metformin (20% against 16%).[1] Diabetes guidelines advise considering periodic B12 checks, especially with anaemia or nerve symptoms.[2]
- People on long-term acid suppression. Proton-pump inhibitors and H2-blockers cut the stomach acid needed to free B12 from food. Taking metformin as well gives you two separate reasons to get checked; an analysis of US drug-safety reports hinted the combination may be worse, but found no clear evidence that the two drugs interact.[3]
- Adults past about 60. Atrophic gastritis, a thinning of the stomach lining that reduces the acid and intrinsic factor B12 needs, affects about 8–9% of adults over 65, against 2% of the general population.[4]
For acid-suppressant users, UK guidance is to get tested if you have symptoms such as tiredness, anaemia, or tingling or numbness;[5] the same approach makes sense after 60. For any of these groups, a low-dose supplement is a cheap, low-risk alternative.
In recent US survey data, where fortified foods and supplements are common, about 4% of adults, over-60s included, had clearly low blood B12, and about 1 in 8 were borderline.[6] The reason to watch B12 after 60 is that absorbing it from food gets harder, not a fixed deficiency rate.
B12: test it properly, buy it cheap
Blood B12 alone is an insensitive test. The body defends blood levels at the expense of tissue stores, so a "normal" result can hide a real shortfall inside cells. Two functional markers, methylmalonic acid (MMA) and homocysteine, rise before blood B12 falls, so unclear cases should be confirmed with MMA or holotranscobalamin, the fraction of B12 available to cells. MMA also rises with poor kidney function and with age, so a high value needs reading alongside kidney function.[7] In a US survey sample of 747 adults with heart failure, those with the highest MMA had about 50% higher risk of death than those with the lowest, even though blood B12 itself was not linked to death.[8] How often to test is covered in Midlife labs.
The form doesn't matter. B12 is sold cheaply as cyanocobalamin and at a premium as methylcobalamin, the active coenzyme form. There is no evidence that the body absorbs supplemental B12 differently by form, or that tablets dissolved under the tongue beat swallowed ones.[9] Methylcobalamin skips a conversion step, which is real biochemistry, but it has not translated into a clinical edge.
The dose: 25–250 µg a day for prevention in an at-risk group; 1,000 µg a day for documented deficiency. High oral doses work even when absorption is impaired by drugs or gastritis, because 1–2% crosses the gut by passive diffusion. B12 has no established upper limit; the European Food Safety Authority (EFSA) found no defined adverse effects.
The brain: a very small effect
Homocysteine is the reason people take B vitamins for the ageing brain. It is an independent risk factor for brain shrinkage and cognitive decline, and B6, folate and B12 clear it. The trials agree that the effect on thinking is very small. The largest recent meta-analysis, 17 trials in about 5,300 adults aged 60 or older, found a very small benefit on overall thinking ability once outlier and single-blind trials were set aside: probably too small to notice in daily life, and similar whether people had normal cognition, mild impairment or dementia. It did not test whether people with high homocysteine gain more.[10]
The optimistic case rests on one British trial. VITACOG, in adults with mild cognitive impairment, found that high-dose B6, folate and B12 slowed whole-brain shrinkage by 29.6%, and by 53.3% in the quarter with the highest homocysteine (above 13 µmol/L).[11] It measured brain scans, not thinking, and its subgroup figures are fragile because they were not adjusted for multiple comparisons. A re-analysis found the benefit only in people with good blood levels of omega-3,[12] but post-hoc checks of two other trials did not confirm this cleanly; in one, people with low omega-3 benefited more.[13]
So the brain case is worth considering mainly in older adults with documented high homocysteine. Pairing B vitamins with adequate omega-3 is reasonable, not required. VITACOG's B6 dose, 20 mg a day, was above the 12 mg limit discussed below. See Dementia prevention.
Folate: either form works
Folate (B9) comes as natural food folate, synthetic folic acid in fortified foods and cheap supplements, and 5-MTHF ("methylfolate"), sold as the active form. The usual pitch for methylfolate is the common MTHFR gene variant, which slows the conversion of folate to its active form; in the United States more people carry one or two copies than don't. But the US Centers for Disease Control and Prevention states that people with these variants can still process all types of folate, including folic acid, and that the variant is not a reason to avoid it.[14] In a randomised trial in 144 healthy women, 5-MTHF lowered homocysteine about as well as folic acid.[15] No trial shows better health outcomes with methylfolate; it is a reasonable choice, not a necessity.
Its one real advantage is that it leaves no unmetabolised folic acid in the blood. High folic-acid intakes can outrun the body's conversion capacity, and the leftover has uncertain long-term significance. Plenty of folate can also mask the anaemia that would signal a hidden B12 deficiency, delaying its diagnosis, and when B12 is low, a high blood folate has been associated with worse cognition.[16] With so much food fortified, adequate B12 matters more, not less.
For pregnancy the answer is settled: women who could become pregnant should take folic acid, the form with the deepest evidence. When Canada made fortification mandatory, neural-tube defects fell by 46%.[17]
On cancer, a randomised polyp-prevention trial found that 1 mg a day of folic acid did not prevent colorectal polyps and was associated with more advanced and multiple ones.[18] Pooled trials of about 50,000 people, at doses roughly ten times what fortification provides, found no significant difference in colorectal or overall cancer over about five years.[19] High doses warrant some caution; no effect on cancer rates has been shown in trials. The upper limit, 1,000 µg a day, covers folic acid and methylfolate from supplements and fortified foods combined.
B6: the one with a real ceiling
Vitamin B6 is the B vitamin most worth being careful with, because more is not safer. Months to years above the intake limit can cause a sensory peripheral neuropathy: tingling and numbness in the hands and feet. It usually stops if the supplement is stopped as soon as symptoms appear,[20] but not always: in Australia's 2025 review, 103 people reported severe and sometimes permanent effects, including nerve damage and muscle weakness, and the regulator concluded that neuropathy can occur at 50 mg a day or even lower.[21] Australia has required a warning on products above 10 mg a day since 2022,[22] and from June 2027 doses above 50 mg will need a pharmacist's advice (above 200 mg already needs a prescription). Australia's own upper limit, 50 mg a day, is itself under review.
EFSA's upper limit for adults is 12 mg a day, counting food and supplements together, far below the doses in many "energy" and "stress" B-complex formulas.[23] Check the label against it. The active form, pyridoxal-5-phosphate (P5P), does not exempt you.
Two observational signals add to the case against high-dose B6 and B12 without a documented deficiency. Both are associations, open to confounding, not proof of harm:
- Lung cancer, in men. In a cohort of 77,118 people, long-term use of individual supplements was tied to nearly doubled lung-cancer risk in men, for B6 above 20 mg a day and for B12 above 55 µg a day, highest in current smokers. There was no link in women and none from multivitamins.[24] Later work pooling blood samples from 20 cohorts, plus a genetic analysis, found more lung cancer in people with higher blood B12, though the genetic result was borderline and the studies measured blood levels, not supplements.[25]
- Hip fracture. In the Nurses' Health Study (75,864 women), a combined high intake of B6 and B12 was linked to more hip fractures. B12 alone carried no such signal, so older adults who need B12 should not be put off.[26]
The heart: a marker, not a lever
Lowering homocysteine with B vitamins did not prevent heart attacks or cardiovascular death. The large trials that lowered it successfully, in people with vascular disease, after a heart attack and after a stroke, were null on those outcomes.[27] A 2017 Cochrane review of 15 trials, about 71,000 adults, found no effect on heart attacks or death, but a small reduction in stroke: 4.3% of people on B vitamins had a stroke against 5.1% on the comparison, about 10% lower.[28]
That stroke benefit looks like a deficiency-correction effect. The clearest positive trial, in 20,702 Chinese adults with high blood pressure, low folate and no food fortification, cut first strokes by 21% with folic acid (2.7% against 3.4% over 4.5 years).[29] Pooled across 21 trials, the benefit appeared in regions without full grain fortification and not in fully fortified ones.[30] Diets richer in several B vitamins go with 10–20% lower stroke risk in two large US cohorts, but that is observational, not evidence that pills help.[31]
Homocysteine is still a useful readout: a raised value is a reason to look for and correct low B12, folate or B6. No trial shows that pushing an already-normal value lower improves health.
Niacin and NAD+: skip the boosters
Vitamin B3 is the raw material for NAD+ (nicotinamide adenine dinucleotide), a coenzyme central to energy metabolism and DNA repair, and the basis of the NMN and NR (nicotinamide mononucleotide, nicotinamide riboside) supplements sold as anti-ageing. They reliably raise blood NAD+, but the functional results in people have been small and inconsistent, and the longevity claims rest on animal data and surrogate markers; see Geroprotectors. The premise is shaky too: a 2026 study of seven groups of people found that NAD+ in whole blood stays stable with age, though blood is not muscle or brain.[32]
A 2024 study added a caution. Two breakdown products of niacin and NAD+, 2PY and 4PY, were associated with higher three-year risk of major cardiovascular events, and 4PY drove artery inflammation in mice. The paper notes that NR and NMN also raise them, a reason for caution rather than proof of harm.[33]
Plain niacin (nicotinic acid) once anchored cholesterol treatment, but two large trials retired it: one was halted early for futility, and in the other, of 25,673 people, it added no cardiovascular benefit on top of statins while raising new-onset diabetes, infection and bleeding.[34] It also causes an uncomfortable flush, and EFSA's upper limit for supplemental nicotinic acid is just 10 mg a day. The other form, nicotinamide, has a 900 mg limit and one niche with trial support: in people who had already had two or more non-melanoma skin cancers, 500 mg twice a day (1,000 mg in all, slightly above that limit) cut new ones by about a quarter over a year.[35] That is a treatment for a skin-cancer history, not a longevity supplement; see Nicotinamide.
The rest: thiamine, riboflavin, B5 and biotin
None has a stand-alone longevity case, but two have real niche uses.
- Thiamine (B1) is critical for nerve function, and deficiency is reversible and often missed. The at-risk groups go beyond heavy drinking (the classic cause of Wernicke encephalopathy): before and after bariatric surgery, refeeding syndrome, and heart failure on long-term loop diuretics, though how common it is in stable heart failure is uncertain. Repletion in these groups is well established.
- Riboflavin (B2) at 400 mg a day roughly quadrupled the share of migraine patients who responded in a trial (59% against 15%), a cheap and moderately well-evidenced preventive.[36] In one trial of 91 treated hypertensive people with two copies of the MTHFR 677TT variant (about 10% of the population), 1.6 mg a day for 16 weeks lowered systolic pressure by about 6 mmHg more than placebo.[37] A senescence effect has been seen only in lab-grown cells.[38]
- Pantothenic acid (B5) deficiency from diet is almost unheard of.
- Biotin (B7) megadoses, common in hair-and-nail products, are mostly harmless but interfere with many laboratory tests, including thyroid and troponin tests. Stop them before bloodwork.
EFSA has set no upper limit for B1, B2, B5 or B7 because there is not enough data to derive one, which is not the same as proof that any dose is harmless.
What to actually do
- B12, if you are in a risk group: 25–250 µg a day for prevention, 1,000 µg a day for documented deficiency. Cheap cyanocobalamin is fine.
- Test with MMA or holotranscobalamin, not blood B12 alone.
- Folate, only if you need it: either form; 400 µg of folic acid a day if you could become pregnant.
- Add up your B6 across every product and keep it under 12 mg a day.
- Stop biotin before blood tests.
- Take them whenever you'll remember. No trial has compared morning and evening dosing.
| Vitamin | Sensible adult use | Upper limit (EFSA, adults) |
|---|---|---|
| B6 (pyridoxine / P5P) | Only as part of a complex; watch the dose | 12 mg/day — neuropathy risk rises above it |
| B9 (folate) | Either form if supplementing (5-MTHF optional); folic acid 400 µg for possible pregnancy | 1,000 µg/day (folic acid and 5-MTHF from supplements and fortified foods combined; food folate not counted) |
| B12 (cobalamin) | 25–250 µg/day at-risk; 1,000 µg/day for deficiency | none established |
| B3 (nicotinic acid) | Not a longevity supplement | 10 mg/day (flush) |
| B3 (nicotinamide) | — | 900 mg/day |
| B1, B2, B5, B7 | Diet is almost always sufficient | none established |
Further reading
- Aroda VR et al. Long-term Metformin Use and Vitamin B12 Deficiency in the DPP/DPPOS. J Clin Endocrinol Metab 2016.[39]
- Berg J et al. Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis. Nutr Rev 2025.[40]
- Smith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment (VITACOG). PLoS ONE 2010.[41]
- Jernerén F et al. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr 2015.[42]
- Lamers Y et al. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 2004.[43]
- Brasky TM, White E, Chen CL. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol 2017.[44]
- EFSA. Overview on Tolerable Upper Intake Levels. EFSA, version 11, August 2025.[45]
- Martí-Carvajal AJ et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2017 (15 RCTs, 71,422 participants).[46]
- Ferrell M, Hazen SL et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nat Med 2024.[47]
- Zhang X et al. Intake of B vitamins and their circulating levels in relation to incident stroke in women and men: findings from two national prospective cohorts. Am J Prev Cardiol 2026.[48]